| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-13 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |